• 

  Op-Ed: Meet Voices of Alzheimer’s—And Hear Its Founders’ Take on Aduhelm
• 

  Aduhelm Trial Lack of Diversity Compounded Efficacy Questions
• 

  At Least 9 Alzheimer’s Vaccines in Trials Right Now
• 

  Why Alzheimer’s Trials Are Recruiting Younger Patients
• 

  Alzheimer’s Nasal Vaccine, Protollin, in Clinical Trials
• 

  5 Ways Clinical Trials Test for Alzheimer’s
• 

  New Era for Alzheimer’s Trials: Blood Tests Bring Younger Participants
• 

  Ritalin for Alzheimer’s? Clinical Trial Explores Common ADHD Drug’s Effects For Treating Apathy
• 

  Seizures and Alzheimer’s: An Anti-Seizure Drug May Benefit Memory, Too
• 

  Approved “Water Pill” Bumetanide May Reduce Alzheimer’s Risk
• 

  A Surprising Diagnosis Leads to Advocacy and Fundraising
• 

  Gantenerumab for Alzheimer’s Gets FDA ‘Breakthrough’ Status
• 

  Mind Control: Bluetooth, Brain Health, and Digital Devices
• 

  Q&A: Marc Archambault on Support Networks In Alzheimer’s
• 

  Expert Panel: Can Viruses and Bacteria Cause Alzheimer’s?

Previous567Next